Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer
Status:
Terminated
Trial end date:
2011-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine if it is possible to deliver high dose
radiation in one week while also giving the drug capecitabine for the treatment of pancreatic
cancer prior to surgery, to determine if this treatment can be given safely for the treatment
of pancreatic cancer prior to surgery and, to determine if this treatment can improve the
local control pancreatic cancer prior to surgery compared to historical controls of standard
treatment.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Brigham and Women's Hospital Massachusetts General Hospital